Palatal Implants and Injection Snoreplasty Compared With a Nightly Airway Device for Palate-Driven Snoring

Palatal Implants for Snoring, Injection Snoreplasty and a Nightly Device at a Glance

Palatal implants for snoring stiffen the soft palate with three small braided polyethylene terephthalate (PET) implants. Injection snoreplasty does the same job chemically, with a sclerosant that scars the tissue. Both are permanent. Neither can be undone if the palate turns out not to be your main problem. A nightly airway device changes no anatomy at all, which is both its weakness and its quiet advantage.

You are here because an ENT looked at your velopharynx, the retropalatal segment behind the soft palate, and said the noise starts there. That finding deserves scrutiny first, so it helps to know how confidently a clinician can pin down the vibrating site in your airway. What follows is the evidence, including the parts clinic brochures leave out.

What Each Palatal Stiffening Procedure Does to Your Soft Palate

Every palatal stiffening procedure shares one mechanism. Make floppy tissue less floppy and it stops fluttering. They differ in method, discomfort and evidence.

Soft-palate implants

Three braided PET strips go into the muscular layer of the soft palate under local anaesthetic, in one outpatient appointment. Scar tissue forms around each strip over the following weeks, and that scar is the stiffening. In 30 patients followed for 12 months, snoring frequency fell from 6.9 to 5.0 and loudness from 9.2 to 5.9, with Epworth Sleepiness Scale scores dropping from 7.4 to 5.6 (Khasawneh and colleagues, Future Science OA, 2021).

Implant extrusion is the risk consumer pages name without measuring. In that same series the partial extrusion rate was 6.7% at 12 months, so roughly one patient in fifteen had an implant work its way back out through the palatal mucosa. Ask your surgeon what happens if one extrudes.

Injection snoreplasty

A sclerosant is injected into the submucosa of the soft palate. Published European series used an ethanol sclerosant at 50 to 75%, or 2 ml of sodium tetradecyl sulfate at 1% or 3% (Olszewska and colleagues, Otolaryngologia Polska, 2014). The injection deliberately creates a mucosal ulcer, and that ulcer heals into a stiffer, scarred palate. Hence the other name, sclerotherapy of the soft palate. Published series describe roughly half of patients returning for a second injection at six to eight weeks. The uvula and palate stay sore for days.

Sodium tetradecyl sulfate is licensed in Europe as a varicose-vein sclerosant, so injecting it into the soft palate is off-label use of a licensed medicine rather than an approved device. That is a prescriber decision under national rules, and a fair question to ask.

Radiofrequency ablation of the soft palate

Heat lesions from a needle electrode shrink and stiffen the palate over the following weeks, a technique also called somnoplasty. A separate guide covers what a radiofrequency session involves and who it suits. In the one published trial putting two of these techniques directly against each other, 70 patients with simple snoring were treated: 87.5% were satisfied after controlled-temperature radiofrequency against 76.7% after injection snoreplasty, with similar discomfort in both groups (Iseri and Balcioglu, Otolaryngology-Head and Neck Surgery, 2005).

What Most Guides on Palatal Implants for Snoring Leave Out

Two things are missing from nearly every page ranking for palatal implants for snoring: the regulatory verdict, and what happens after the first year.

Flaw one, implants presented as a routine orderable option

They are not, at least not in the United Kingdom. NICE guidance HTG154, formerly interventional procedures guidance IPG240, states that the evidence on efficacy "is based on small case series only and there is a lack of well-controlled and comparative data. Therefore, this procedure should only be used in the context of research" (NICE, 2007). Its companion guidance HTG155 finds "inadequate evidence that the procedure is efficacious" for obstructive sleep apnoea (NICE, 2007). No NICE guidance exists for injection snoreplasty at all.

Availability is the second surprise. A leading sleep-surgery reference site states that the branded implant procedure is not currently available because the implants are no longer manufactured. Treat that as a single source worth checking, not settled fact. No consumer page tells you to ask.

Flaw two, results described as if they were permanent

Long-term data says otherwise. When the original snoreplasty cohort was followed to a mean of 19 months, subjective success fell from 92% to 75%, with an 18% snoring relapse rate (Brietzke and Mair, Otolaryngology-Head and Neck Surgery, 2003). The 2025 systematic review in the Journal of Clinical Medicine pooled 43 studies and 2,713 patients and stated that most studies report only mid-term follow-up of six to twelve months, giving no perspective on the stability of results. It judged most studies to carry serious or critical risk of bias (Cammaroto and colleagues, 2025).

Then the placebo problem. A double-blind randomised trial at University Medical Centre Mannheim treated 22 patients with mild to moderate obstructive sleep apnoea. The apnoea-hypopnoea index, hypopnoea index and lowest oxygen saturation improved within the treatment group, yet there was no statistical difference against the placebo group (Maurer and colleagues, European Archives of Oto-Rhino-Laryngology, 2012). A Cochrane review of 12 randomised trials and 709 participants concluded that surgery cannot be recommended as a front line therapy ahead of positive airways pressure. The peer-reviewed paper ranking near the top of this search, meanwhile, is a case report of one 56-year-old man followed for two months (Choi and colleagues, Clinical and Experimental Otorhinolaryngology, 2014).

How Your ENT Decided the Palate Is the Vibrating Site

The palate diagnosis is only as good as the test behind it, and two tests do most of that work.

The Muller manoeuvre asks you to inhale against a closed nose and mouth while a scope watches the airway collapse. Quick, cheap, and awake, which is the problem: your muscle tone at 3am is nothing like it is in the chair. Drug-induced sleep endoscopy, or DISE, sedates you into something closer to sleep and grades the airway with the VOTE classification, scoring velum, oropharynx, tongue base and epiglottis separately.

That distinction decides everything. Anteroposterior palatal collapse, the palate flapping front to back, is what palatal stiffening targets and what drives classic palatal flutter snoring. Lateral pharyngeal wall collapse and tongue-base collapse are different mechanical problems, and stiffening the palate does little for either. Most published palate results come from patients never phenotyped this way: fewer than half the studies in the 2025 review's quantitative analysis used DISE at all.

Where a Reversible Nightly Device Fits Against Palatal Implants for Snoring

A nightly device works the other way round. Rather than stiffening the palate, it holds the segment open so there is less for the tissue to flutter against.

A Swiss study at Kantonsspital Baselland tested a nasopharyngeal stent in 122 patients with sleep-related breathing disorders, 101 of them analysable. Cross-referenced against sleep endoscopy, the stent significantly reduced the apnoea-hypopnoea index in patients with palatal obstruction, mainly anteroposterior collapse, and did not influence retrolingual or multilevel obstruction. Using a 40% AHI reduction as the cut-off, 85.7% of soft palate obstructions were detected compared with DISE (Dellweg, Kampmann and Tschopp, The Journal of International Medical Research, 2022). That is the same segment palatal implants for snoring aim to stiffen, approached without scarring.

That study did not test Back2Sleep, but it tested the same device class placed by the same route. Back2Sleep is a CE-certified Class I soft silicone nasopharyngeal stent from a French company in Paris, passed through the nostril to sit behind the soft palate and keep the nasal airway open during sleep. No electricity, no noise, no tubing, no prescription, and a starter kit of four sizes at around EUR 39 with a 30-day money-back window. It is for snoring and mild to moderate obstructive sleep apnoea, never severe disease, and it does not replace prescribed positive airway pressure.

The honest limitations

Tolerance is the real constraint. In that Swiss cohort, 14 of 122 patients were excluded because they could not tolerate the stent, roughly one in nine, and the authors concluded that a stent of this class is not readily tolerated. It is also not a nasal dilator or an adhesive strip. A 2026 meta-analysis in Cureus covering 17 studies and 496 participants found no significant difference in AHI or snoring index with nasal dilators, and concluded they cannot be recommended as monotherapy. Different level of the airway, different job.

The asymmetry is the whole point. A device that fails costs you a few weeks and a small sum. A scarred palate that fails is permanent, and stays permanent if the real problem was the lateral wall all along.

What This Costs in Europe, and What Anyone Reimburses

Almost nothing, for simple snoring. That is the short answer across most of Europe, and the widest gap between American consumer pages and your reality.

In the United Kingdom, published private quotes include around GBP 1,000 for palatal implants for snoring at a clinic and GBP 2,695 for a full private snoring-surgery package with consultations and endoscopic assessment. NHS funding for a procedure NICE limits to research settings is unlikely. In France, Assurance Maladie reimburses an orthèse d'avancée mandibulaire, the mandibular advancement device, only for diagnosed obstructive sleep apnoea, first line for moderate disease at an IAH of 15 to 30 per hour, and only with entente préalable from your caisse. Isolated snoring without apnoea attracts essentially nothing, procedure or device.

The vocabulary problem

The same condition carries different names across Europe, which makes comparing quotes harder. Simple snoring in UK usage matches the international term isolated snoring, the French ronchopathie or ronflement isole, and the German primares Schnarchen. The apnoea-hypopnoea index is written AHI in English and IAH in French. Palatal implants appear on French clinic sites as implants palatins.

A Four-Step Plan Before You Book Any Palatal Procedure

The most recent framework for your situation is European. An international consensus on isolated snoring, published in the European Annals of Otorhinolaryngology, Head and Neck Diseases in 2026, ran a two-round Delphi with 35 experts from 16 countries; 44 of 58 statements reached agreement at a 75% threshold. Severity should be graded on snoring frequency, your bed partner's complaint and the couple's quality of life rather than acoustic measurement alone. Nasal obstruction is a treatable comorbidity that may be assessed first.

If you still want a procedure, take these four questions with you.

1. Can you obtain the implants, and when did you last place a set?
2. Did my sleep endoscopy show anteroposterior collapse, or was the lateral wall involved?
3. What is your relapse rate beyond twelve months, in your own patients?
4. What is the total out-of-pocket cost, including follow-up?

Palatal implants for snoring, snoreplasty and radiofrequency sit on the same ladder as heavier surgery, from laser-assisted uvulopalatoplasty (LAUP) to uvulopalatopharyngoplasty (UPPP). For someone whose main complaint is bed partner sleep disruption, and for whom positive airway pressure was never indicated or was abandoned through CPAP intolerance, the reversible option deserves the first trial.

Frequently Asked Questions